Taho Pharmaceuticals Ltd. (TPE:6467)
202.50
+15.50 (8.29%)
At close: Oct 22, 2026
| Market Cap | 10.61B +26.3% |
| Revenue (ttm) | 1.98M -74.5% |
| Net Income | -238.34M |
| EPS | -4.58 |
| Shares Out | 52.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,090,297 |
| Open | 186.00 |
| Previous Close | 187.00 |
| Day's Range | 184.00 - 212.00 |
| 52-Week Range | 100.50 - 302.00 |
| Beta | -0.94 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |